Gupta Dhaval, Ingle Meghraj, Shah Kaivan, Phadke Aniruddha, Sawant Prabha
Department of Gastroenterology, Lokmanya Tilak Municipal Medical College & Hospital, Mumbai, India.
J Dig Dis. 2015 Jul;16(7):400-7. doi: 10.1111/1751-2980.12248.
This study aimed to determine the usefulness of inhibitory control test (ICT) for diagnosing minimal hepatic encephalopathy (MHE) in the Indian subcontinent and its correlation with the severity of liver disease and to determine its prognostic significance.
Two hundred patients with cirrhosis and 200 healthy controls were enrolled. Only patients were administered with psychometric hepatic encephalopathy score (PHES), while both patients and controls were subjected to ICT. MHE was diagnosed when PHES ≤ -5. ICT was considered abnormal when the numbers of ICT lures were ≥ 14.
Overall, 135 (67.5%) patients had MHE. Mean ICT lures were higher in cirrhotic patients with MHE than those without MHE (17.27, 95% confidence interval [CI] 13.9-22.3 vs 8.79, 95% CI 6.8-12.60, P < 0.001). Target accuracy was lower in patients with MHE than in those without (84.35, 95% CI 78.5-89.8 vs 95.36, 95% CI 90.1-99.2, P < 0.001). ICT had a sensitivity of 92.6% and specificity of 78.5% with the area under the receiver operating characteristic curve of 0.855 (95% CI 0.791-0.920) for MHE. ICT was correlated with Child-Turcotte-Pugh class (P < 0.001) and the model for end-stage liver disease score (P < 0.001) and predicted the development of overt hepatic encephalopathy (OHE) and probable survival with excellent test-retest reliability.
ICT is useful for diagnosing MHE in patients with cirrhosis. It is correlated with disease severity and predicts the development of OHE and probable survival with excellent test-retest reliability.
本研究旨在确定抑制控制测试(ICT)在印度次大陆诊断轻微肝性脑病(MHE)中的作用及其与肝病严重程度的相关性,并确定其预后意义。
招募了200例肝硬化患者和200名健康对照者。仅对患者进行心理测量肝性脑病评分(PHES),而患者和对照者均接受ICT。当PHES≤-5时诊断为MHE。当ICT诱饵数≥14时,ICT被认为异常。
总体而言,135例(67.5%)患者患有MHE。患有MHE的肝硬化患者的平均ICT诱饵数高于未患MHE的患者(17.27,95%置信区间[CI]13.9 - 22.3 vs 8.79,95%CI 6.8 - 12.60,P < 0.001)。患有MHE的患者的目标准确率低于未患MHE的患者(84.35,95%CI 78.5 - 89.8 vs 95.36,95%CI 90.1 - 99.2,P < 0.001)。ICT对MHE的敏感性为92.6%,特异性为78.5%,受试者工作特征曲线下面积为0.855(95%CI 0.791 - 0.920)。ICT与Child-Turcotte-Pugh分级(P < 0.001)和终末期肝病模型评分(P < 0.001)相关,并预测显性肝性脑病(OHE)的发生和可能的生存率,具有出色的重测信度。
ICT对诊断肝硬化患者的MHE有用。它与疾病严重程度相关,并预测OHE的发生和可能的生存率,具有出色的重测信度。